Leptin levels in protracted critical illness: Effects of growth hormone- secretagogues and thyrotropin-releasing hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3062-3070

  Van Den Berghe, Greet ^a,e   Wouters, Pieter ^a   Carlsson, Lena ^b   Baxter, Robert C ^c   Bouillon, Roger ^a   Bowers, Cyril Y ^d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SYDNEY   (Australia)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FUND FOR SCIENTIFIC RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; HYPOTHALAMUS RELEASING FACTOR; INSULIN; LEPTIN; LIOTHYRONINE; PLACEBO; PRALMORELIN; PROTEIN SUBUNIT; PROTIRELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROXINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; ENTERIC FEEDING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BODY MASS INDEX; CRITICAL ILLNESS; CROSS-OVER STUDIES; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MIDDLE AGED; OLIGOPEPTIDES; PROTEINS; THYROID HORMONES; THYROTROPIN-RELEASING HORMONE;

EID: 0031741773     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3062     Document Type: Article

References (54)

1. Streat SJ, Beddoe AH, Hill GL. 1987 Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 27:262-266.
2. Gamrin L, Essén P, Forsberg AM, Hultman E, Wernerman J. 1996 A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med. 24:575-583.
3. Vermes I, Bieshuizen A, Hampsink RM, Haanen C. 1995 Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. 80:1238-1242.
4. Van den Berghe G, de Zegher F, Veldhuis JD, et al. 1997 The somatotropic axis in critical illness: effect of continuous GHRH and GHRP-2 infusion. J Clin Endocrinol Metab. 82:590-599.
5. Van den Berghe G, de Zegher F, Veldhuis JD, et al. 1997 Thyrotropin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone secretagogues. Clin Endocrinol (Oxf). 47:599-612.
6. Van den Berghe G, de Zegher F, Baxter RC, et al. 1998 Neuroendocrinology of critical illness: effect of continuous thyrotropin-releasing hormone infusion and its combination with growth hormone-secretagogues. J Clin Endocrinol Metab. 83:309-319.
7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human analogue. Nature. 372:425-432.
8. Considine RV, Sinha MK, Hainman ML, et al. 1996 Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 334:292-295.
9. Ostlund Jr RE, Yang JW, Klein S, Gingerich R. 1996 Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 81:3909-3913.
10. Greenspoon S, Gulicl T, Askari H, et al. 1996 Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 81:3861-3863.
11. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF. 1996 Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 97:1344-1347.
12. Licinio J, Mantzoros C, Negrao AB, et al. 1997 Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Med. 3:575-579.
13. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes. 45:699-701.
14. Boden G, Chen X, Kolaczynski JW, Polansky M. 1997 Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest. 100:1107-1113.
15. Boden G, Chen X, Mozzoli M, Ryan I. 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 81:3419-3423.
16. Florkowski CM, Collier GR, Zimmet PZ, Livesey JH, Espiner EA, Donald RA. 1996 Low-dose growth hormone replacement lowers plasma leptin stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 45:769-773.
17. Bianda TL, Glatz Y, Boeni-Schnetzler M, Froesch ER, Schmid C. 1997 Effects of growth hormone (GH) and insulin-like grnwlh factor-I on serum leptin in GH-deficient adults. Diabetologica. 40:363-364.
18. Berneis K, Vosmeer S, Keller U. 1996 Effects of glucucorticoids and of growth hormone on serum leptin concentrations in man. Eur J Endocrinol. 135:663-665.
19. Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C. 1997 Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab. 82:1632-1634.
20. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW. 1997 Robust secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab. 82:3230-3233.
21. Korbonits M, Trainer PJ, Little JA, et al. 1997 Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf). 46:751-757.
22. Janik JE, Curti BD, Considine RV, et al. 1997 Interleukin 1α increases serum leptin concentrations in humans. J Clin Endocrinol Metab. 82:3084-3086.
23. Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. 1997 Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab. 82:4080-4082.
24. Bornstein SR, Licinio J, Tauchnitz R, Engelman L, Negrao AB, Chrousos GP. 1998 Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm in cortisol and leptin secretion. J Clin Endocrinol Metab. 83:280-281.
25. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. 1997 Isoproterenol and somatostatin decrease plasma leptin in humans: a noval mechanism regulating leptin secretion. J Clin Endocrinol Metab. 82:4139-4134.
26. Barinaga M. 1995 'Obese' protein slims mice. Science. 269:475-476.
27. Pelleymounter MA, Cullen MJ, Baker MB, et al. 1995 Effect of the obese gene on body weight reduction in ob/ob mice. Science. 269:540-543.
28. Halaas JL, Gaijwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543-546.
29. Romsos DR, Swick AG, Chruncyk BA, Cunningham D, Mistry AM. 1996 Intracerebroventricular recombinant leptin decreases food-intake and increases metabolic rate in ob/ob mice. FASEB J. 10:1287.
30. Mercer JG, Hoggard N, Williams LM, et al. 1996 Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinology. 8:733-735.
31. Devos R, Richards JG, Campfield LA, et al. 1996 OB protein binds specifically to the choroid plexus of mice and rats. Proc Natl Acad Sci USA. 93:5668-5673.
32. Ahima RS, Prabrakan D, Mantzoros C, et al. 1996 Role of leptin in the neuroendocrine response to fasting. Nature. 383:250-252.
33. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 138:2569-2576.
34. Caro E, Senaris R, Considine RV, Casanueva FF, Dieguez C. 1997 Regulation of in vivo growth hormone secretion by leptin. Endocrinology. 138:2203-2206.
35. Shimabukuro M, Koyama K, Chen G, et al. 1997 Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA. 94:4637-4641.
36. Müller G, Ertl J, Gerl M, Preibisch G. 1997 Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem. 272:10585-10593.
37. Frohman LA, Jansson JO. 1986 Grnwlh hormone-releasing hormone. Endocr Rev. 7:223-253.
38. Jackson IMD. 1982 Thyrotropin releasing hormone. N Engl J Med. 306:145-155.
39. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1537-1545.
40. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. 1994 Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab. 79:1141-1146.
41. Van den Berghe G, de Zegher F. 1996 Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med.24:1580-1590.
42. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985 Apache II: a severity of disease classification system. Crit Care Med. 13:818-829.
43. Souba WW. 1997 Nutritional support. N Engl J Med. 336:41-48.
44. Mizock BA. 1995 Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 98:75-84.
45. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest. 78:1504-1512.
46. Baxter RC. 1990 Circulating levels and molecular distribution of the acid-dabile (α) subunit of the high molecular weight insulin-like growth factor-binding protein complex in normal subjects. J Clin Endocrinol Metab. 70:1347-1353.
47. Gettys TW, Harkness PJ, Watson PM. 1996 The β-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology. 137:4054-4057.
48. Mantzoros CS, Qu D, Frederich RC, et al. 1996 Activation of β3-adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45:909-914.
49. Vermeulen A. 1987 Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C-levels. J Clin Endocrinol Metab. 64:884-888.
50. Howard AD, Feighner SD, Cully DF, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974-977.
51. Van den Berghe G, de Zegher F, Bowers CY, et al. 1996 Pituitary responsiveness to growth hormone (GH) releasing hormone, GH-releasing peptide-2 and thyrotropin releasing hormone in critical illness. Clin Endocrinol (Oxf). 45:341-351.
52. Hardie LJ, Guilhot N, Trayhurn P. 1996 Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res. 28:685-689.
53. Russell-Jones DL, Umpleby M. 1996 Protein anabolic action of insulin, growth hormone and insulin-like growth factor I. Eur J Endocrinol. 135:631-642.
54. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-1 by use of both agents simultaneously. J Clin Invest. 91:391-396.